Recent advances in target identification of bioactive natural products
- PMID: 30343630
- DOI: 10.1080/09168451.2018.1533804
Recent advances in target identification of bioactive natural products
Abstract
Natural products are a tremendous source of tool discovery for basic science and drug discovery for clinical uses. In contrast to the large number of compounds isolated from nature, however, the number of compounds whose target molecules have been identified so far is fairly limited. Elucidation of the mechanism of how bioactive small molecules act in cells to induce biological activity (mode of action) is an attractive but challenging field of basic biology. At the same time, this is the major bottleneck for drug development of compounds identified in cell-based and phenotype-based screening. Although researchers' experience and inspiration have been crucial for successful target identification, recent advancements in genomics, proteomics, and chemical genomics have made this challenging task possible in a systematic fashion.
Keywords: Chemical genetics; mode of action; profiling; target molecule; yeast genetics.
Similar articles
-
Small molecule enabled chemical biology and drug discovery.Bioorg Med Chem. 2017 Jun 1;25(11):2815-2816. doi: 10.1016/j.bmc.2017.05.025. Bioorg Med Chem. 2017. PMID: 28532738 No abstract available.
-
Natural products: Beyond grind and find.Nat Chem. 2009 Jul;1(4):261-3. doi: 10.1038/nchem.269. Nat Chem. 2009. PMID: 21378864 No abstract available.
-
Chemistry and Chemical Biology of Therapeutically Important Compounds.Bioorg Med Chem. 2016 Sep 1;24(17):3875. doi: 10.1016/j.bmc.2016.06.049. Epub 2016 Jun 27. Bioorg Med Chem. 2016. PMID: 27460698 No abstract available.
-
Strategies for target identification of antimicrobial natural products.Nat Prod Rep. 2016 May 4;33(5):668-80. doi: 10.1039/c5np00127g. Nat Prod Rep. 2016. PMID: 26806527 Review.
-
Chemical-genetic approaches for exploring the mode of action of natural products.Prog Drug Res. 2008;66:237, 239-71. doi: 10.1007/978-3-7643-8595-8_5. Prog Drug Res. 2008. PMID: 18416308 Review.
Cited by
-
PROTAC derivatization of natural products for target identification and drug discovery: Design of evodiamine-based PROTACs as novel REXO4 degraders.J Adv Res. 2024 Sep;63:219-230. doi: 10.1016/j.jare.2023.10.014. Epub 2023 Oct 31. J Adv Res. 2024. PMID: 37913903 Free PMC article.
-
Unveiling p65 as the target of diphyllin in ameliorating metabolic dysfunction-associated steatotic liver disease via targeted protein degradation technology.Front Pharmacol. 2025 Apr 28;16:1567639. doi: 10.3389/fphar.2025.1567639. eCollection 2025. Front Pharmacol. 2025. PMID: 40356997 Free PMC article.
-
Multi-omics approaches: transforming the landscape of natural product isolation.Funct Integr Genomics. 2025 Jun 19;25(1):132. doi: 10.1007/s10142-025-01645-7. Funct Integr Genomics. 2025. PMID: 40537580 Review.
-
Development of Procathepsin L (pCTS-L)-Inhibiting Lanosterol-Carrying Liposome Nanoparticles to Treat Lethal Sepsis.Int J Mol Sci. 2023 May 12;24(10):8649. doi: 10.3390/ijms24108649. Int J Mol Sci. 2023. PMID: 37239992 Free PMC article.
-
Discovery of a Natural Product That Binds to the Mycobacterium tuberculosis Protein Rv1466 Using Native Mass Spectrometry.Molecules. 2020 May 21;25(10):2384. doi: 10.3390/molecules25102384. Molecules. 2020. PMID: 32455540 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources